Knockdown of TLR4 by shRNA in glioma CD133+ CSCs inhibited LPS-stimulated CSC proliferation and reversed the inhibitory effect of LPS-induced glioma CD133+ CSCs on the cytotoxicity of CTLs. This evidence concerns the gene PROM1 and glioma.